Thyrosafe Tablet
Product Images NDC 50633-910

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Thyrosafe (NDC 50633-910). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Btg International Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (65 mg Carton Label)

ThyroSafe Potassium Iodide Tablets USP, 65 mg, oral tablets packaging label. The label indicates 20 tablets per container, manufactured by BTG International Inc. It features drug facts including active ingredient, warnings, and directions for use as a thyroid blocking agent during a nuclear radiation emergency. The label also displays the product NDC 50633-910-20 and barcodes.*

FDA Label Image

Principal Display Panel (65 mg Carton Label)

Packaging label artwork for ThyroSafe Potassium Iodide Tablets, USP 65 mg, showing the printed foil blister layout with multiple tablet compartments. Each compartment is labeled with the brand name ThyroSafe, strength 65 mg, and active ingredient Potassium Iodide Tablets, USP. The label indicates manufacturer information and batch/expiration placeholders. Dimensions and technical specs are included in the design, produced by Recipharm.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.